Cargando…
Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
BACKGROUND: The Pharmacovigilance Program of India recommends the use of the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) scale, while many clinicians prefer the Naranjo algorithm for its simplicity. In the present study, we assessed agreement between the two widely used causality a...
Autores principales: | Shukla, Ajay K., Jhaj, Ratinder, Misra, Saurav, Ahmed, Shah N., Nanda, Malaya, Chaudhary, Deepa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565125/ https://www.ncbi.nlm.nih.gov/pubmed/34760748 http://dx.doi.org/10.4103/jfmpc.jfmpc_831_21 |
Ejemplares similares
-
A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions
por: Belhekar, Mahesh N., et al.
Publicado: (2014) -
Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools
por: Mittal, Niti, et al.
Publicado: (2015) -
Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines
por: Jhaj, Ratinder, et al.
Publicado: (2022) -
A case report on azathioprine-induced euprolactinemic galactorrhea
por: Chaudhary, Deepa, et al.
Publicado: (2021) -
Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough
por: Jhaj, Ratinder, et al.
Publicado: (2021)